A carregar...
XPA Enhances Temozolomide Resistance of Glioblastoma Cells by Promoting Nucleotide Excision Repair
Glioblastoma is the most frequent, as well as aggressive kind of high-grade malignant glioma. Chemoresistance is posing a significant clinical barrier to the efficacy of temozolomide-based glioblastoma treatment. By suppressing xeroderma pigmentosum group A (XPA), a pivotal DNA damage recognition pr...
Na minha lista:
Main Authors: | , , , , |
---|---|
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
SAGE Publishing
2022-05-01
|
Colecção: | Cell Transplantation |
Acesso em linha: | https://doi.org/10.1177/09636897221092778 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|